financetom
Business
financetom
/
Business
/
US FDA declines to approve Viatris's injection for multiple sclerosis
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US FDA declines to approve Viatris's injection for multiple sclerosis
Mar 11, 2024 4:22 AM

March 11 (Reuters) - The U.S. FDA has declined to

approve Viatris ( VTRS ) and Mapi Pharma's once-a-month

injection for the treatment of relapsing forms of multiple

sclerosis, the companies said on Monday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved